AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8131458 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (TI=25 percent, pause=10 percent)
Number of subjects: 11
Study 8131458 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=20 percent) without end-inspiratory pause
Number of subjects: 11
Study 8131458 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=33 percent) without end-inspiratory pause
Number of subjects: 11
Study 8131458 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=50 percent) without end-inspiratory pause
Number of subjects: 11
Study 8131458 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=67 percent) without end-inspiratory pause
Number of subjects: 11
Study 2941056 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 165
Study 2941056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 2941056 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Codeine 30 mg (medium-dose combination)
Number of subjects: 165
Study 2941056 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ibuprofen/codeine combination
Number of subjects: 165
Study 2941056 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ibuprofen/codeine combination
Number of subjects: 165
Study 31556212 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Pain Self-Management Program (CPSMP)
Number of subjects: 394
Study 30247753 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive WM training
Number of subjects: 0
Study 30247753 — intervention group
Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 0
Study 27604571 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge translation intervention employing educational outreach, a point-of-care reminder tool, and a peer support network
Number of subjects: 600
Study 27604571 — intervention group
Group type: COMPARATOR
Intervention: Standard lay health worker training
Number of subjects: 600
Study 24406723 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal orexin-A (435 nmol)
Number of subjects: 14
Study 24406723 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 14
Study 22512266 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration(PRE)
Number of subjects: 20
Study 22512266 — intervention group
Group type: COMPARATOR
Intervention: Calibration(POST)
Number of subjects: 20
Study 19894018 — intervention group
Group type: EXPERIMENTAL
Intervention: GSA scintigraphy (HH15 and LHL15) after partial hepatic resection (Hr0)
Number of subjects: 86
Study 19894018 — intervention group
Group type: EXPERIMENTAL
Intervention: GSA scintigraphy (HH15 and LHL15) after sectionectomy (Hr1)
Number of subjects: 86
Study 19894018 — intervention group
Group type: EXPERIMENTAL
Intervention: GSA scintigraphy (HH15 and LHL15) after bisectionectomy (Hr2)
Number of subjects: 86
Study 19894018 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematobiochemical tests and remnant liver volume monitoring
Number of subjects: 86
Study 18308816 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine treatment
Number of subjects: 26
Study 18308816 — intervention group
Group type: COMPARATOR
Intervention: Unmedicated persons with schizophrenia
Number of subjects: 26
Study 18308816 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 26
Study 16282050 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal drug therapy (glucosidorum Tripterygii totorum tablets and Yishen Juanbi Tablets)
Number of subjects: 413
Study 16282050 — intervention group
Group type: COMPARATOR
Intervention: Western medicine therapy (voltaren extended release tablets, methotrexate, and sulfasalazine)
Number of subjects: 413
Study 12903698 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel dressings
Number of subjects: 106
Study 12903698 — intervention group
Group type: COMPARATOR
Intervention: Lanolin ointment
Number of subjects: 106
Study 10507103 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial hospitalization rehabilitation
Number of subjects: 0
Study 10507103 — intervention group
Group type: COMPARATOR
Intervention: Inpatient rehabilitation
Number of subjects: 0
Study 7851599 — intervention group
Group type: EXPERIMENTAL
Intervention: Semen samples from men with spinal cord injury
Number of subjects: 0
Study 7851599 — intervention group
Group type: EXPERIMENTAL
Intervention: Percoll‐washed spermatozoa from men with spinal cord injury
Number of subjects: 0
Study 7851599 — intervention group
Group type: COMPARATOR
Intervention: Semen samples from healthy volunteers and infertile patients
Number of subjects: 0
Study 2167952 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy at 69.6 Gy
Number of subjects: 848
Study 2167952 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy at 60.0 to 64.8 Gy
Number of subjects: 848
Study 2167952 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy at 69.6 to 74.4 Gy
Number of subjects: 848
Study 2167952 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy at 79.2 Gy
Number of subjects: 848
Study 6102504 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydroemetine
Number of subjects: 40
Study 6102504 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone
Number of subjects: 40
Study 30516419 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-etched surface miniscrews
Number of subjects: 40
Study 30516419 — intervention group
Group type: COMPARATOR
Intervention: Machined surface miniscrews
Number of subjects: 40
Study 28628679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenol mebutate (IngMeb) gel at concentrations of 0.018% and 0.027%, applied once daily for 2 or 3 days
Number of subjects: 0
Study 28628679 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 26117164 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit emotion regulation intervention via psychotherapy (specific dosage and duration not mentioned)
Number of subjects: 0
Study 23846502 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 605
Study 21616527 — intervention group
Group type: EXPERIMENTAL
Intervention: Terutroban (30 mg per day)
Number of subjects: 9562
Study 21616527 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg per day)
Number of subjects: 9562
Study 19004549 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous Botulinum toxin type A (BoNT/A) 22.5U
Number of subjects: 14
Study 19004549 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 14
Study 17530942 — intervention group
Group type: EXPERIMENTAL
Intervention: T. terrestris (450 mg.d(‐1))
Number of subjects: 22
Study 17530942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 17530942 — intervention group
Group type: EXPERIMENTAL
Intervention: T. terrestris
Number of subjects: 22
Study 15126543 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyltestosterone (2.5 mg/d) plus esterified estrogens (1.25 mg/d)
Number of subjects: 0
Study 15126543 — intervention group
Group type: COMPARATOR
Intervention: Esterified estrogens alone
Number of subjects: 0
Study 15126543 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyltestosterone plus esterified estrogens
Number of subjects: 0
Study 15466635 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic heparin treatment throughout the procedure
Number of subjects: 150
Study 15466635 — intervention group
Group type: EXPERIMENTAL
Intervention: Air filters between the catheter and both the contrast medium syringe and the catheter flushing
Number of subjects: 150
Study 15466635 — intervention group
Group type: COMPARATOR
Intervention: Conventional angiographic technique (Control group)
Number of subjects: 150
Study 15466635 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler sonography (Air filter group)
Number of subjects: 150
Study 10519582 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes (self-reported history of physician-diagnosed diabetes or glycosylated hemoglobin > 10%)
Number of subjects: 4631
Study 10519582 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinopathy in black/mixed population regardless of diabetes status
Number of subjects: 4631
Study 10519582 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinopathy in black and mixed participants with diabetes
Number of subjects: 4631
Study 10519582 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically significant macular edema (CSME) in participants with diabetes
Number of subjects: 4631
Study 7627280 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 1488
Study 7627280 — intervention group
Group type: EXPERIMENTAL
Intervention: MESA with ICSI
Number of subjects: 1488
Study 7627280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sperm injection)
Number of subjects: 1488
Study 2117858 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate (MT, 10 mg/kg body weight)
Number of subjects: 100
Study 2117858 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (PR, 40 mg/kg body weight)
Number of subjects: 100
Study 2117858 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 100
Study 6795461 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of vaccine (20 micrograms per dose) at 0, 1 and 6 months
Number of subjects: 0
Study 6795461 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of vaccine (20 micrograms per dose) + 3 ml of HBIG with the first dose
Number of subjects: 0
Study 6795461 — intervention group
Group type: EXPERIMENTAL
Intervention: HBIG together with the first and second doses of vaccine
Number of subjects: 0
Study 6795461 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31112623 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 2 mg
Number of subjects: 36
Study 28064304 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmic artery branch retrograde intervention with urokinase (400,000 U) and papaverine (30 mg)
Number of subjects: 50
Study 28064304 — intervention group
Group type: COMPARATOR
Intervention: Superselective ophthalmic artery/selective carotid intervention with urokinase (400,000 U) and papaverine (30 mg)
Number of subjects: 50
Study 28064304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study 26602322 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 828
Study 26602322 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and clopidogrel in combination prior to CAS
Number of subjects: 828
Study 26602322 — intervention group
Group type: COMPARATOR
Intervention: Open-cell stent
Number of subjects: 828
Study 26602322 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-cell stent
Number of subjects: 828
Study 26602322 — intervention group
Group type: COMPARATOR
Intervention: Cerebral protection device (CPD) use
Number of subjects: 828
Study 26602322 — intervention group
Group type: COMPARATOR
Intervention: Age (per 5 years)
Number of subjects: 828
Study 26602322 — intervention group
Group type: COMPARATOR
Intervention: Right-sided procedure
Number of subjects: 828
Study 24343389 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquacel
Number of subjects: 67
Study 24343389 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediskin I
Number of subjects: 67
Study 24343389 — intervention group
Group type: COMPARATOR
Intervention: Allevyn
Number of subjects: 67
Study 22579409 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious pressure stimulation
Number of subjects: 22
Study 22579409 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls, n=52
Number of subjects: 22
Study 21119312 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injections (intra-articular or subacromial) with local anesthetic
Number of subjects: 38
Study 21119312 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation and therapeutic exercise program
Number of subjects: 38
Study 21119312 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 38
Study 21119312 — intervention group
Group type: COMPARATOR
Intervention: Brunnstrom upper-extremity score
Number of subjects: 38
Study 21119312 — intervention group
Group type: COMPARATOR
Intervention: Modified Ashworth scale
Number of subjects: 38
Study 17986403 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI report seen by surgeons (intervention group)
Number of subjects: 252
Study 17986403 — intervention group
Group type: COMPARATOR
Intervention: No MRI report seen by surgeons (control group)
Number of subjects: 252
Study 16302384 — intervention group
Group type: EXPERIMENTAL
Intervention: Color category shared with distractors
Number of subjects: 0
Study 16302384 — intervention group
Group type: EXPERIMENTAL
Intervention: Color category not shared with distractors
Number of subjects: 0
Study 11987579 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated against influenza
Number of subjects: 375
Study 11987579 — intervention group
Group type: COMPARATOR
Intervention: Non-vaccinated subjects
Number of subjects: 375
Study 11987579 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated and non-vaccinated subjects
Number of subjects: 375
Study 9609601 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational efforts and promotion of information using various media
Number of subjects: 0
Study 7702031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 21906
Study 7702031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21906
Study 31778719 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal contraceptives (HCs)
Number of subjects: 395
Study 31778719 — intervention group
Group type: COMPARATOR
Intervention: Naturally cycling women (NC)
Number of subjects: 395
Study 31778719 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (among NC women)
Number of subjects: 395
Study 31778719 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (among HC women)
Number of subjects: 395
Study 31061017 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 3 mg/day
Number of subjects: 150
Study 31061017 — intervention group
Group type: COMPARATOR
Intervention: liraglutide placebo 3 mg/day
Number of subjects: 150
Study 29979699 — intervention group
Group type: EXPERIMENTAL
Intervention: I-HAES®
Number of subjects: 58
Study 29979699 — intervention group
Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 58
Study 26790823 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomethiazole treatment after 24 hours
Number of subjects: 30
Study 26790823 — intervention group
Group type: COMPARATOR
Intervention: Acute alcohol withdrawal syndrome
Number of subjects: 30
Study 24919813 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/d
Number of subjects: 321
Study 24919813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study 22779218 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpik Complete Care (WFS)
Number of subjects: 139
Study 22779218 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensonic Professional Plus Toothbrush (SPP)
Number of subjects: 139
Study 22779218 — intervention group
Group type: COMPARATOR
Intervention: Sonicare FlexCare (SF)
Number of subjects: 139
Study 22779218 — intervention group
Group type: COMPARATOR
Intervention: Oral-B Indicator manual toothbrush (MT)
Number of subjects: 139
Study 19169140 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg twice daily
Number of subjects: 20
Study 19169140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17982706 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat-based diet
Number of subjects: 57
Study 17982706 — intervention group
Group type: COMPARATOR
Intervention: Vegetable-based diet
Number of subjects: 57
Study 15110806 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymphadenectomy (SL) using technetium 99 m sulfur colloid
Number of subjects: 1094
Study 15110806 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymphadenectomy (SL) in node-negative patients
Number of subjects: 1094
Study 11318256 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents whose parents were unemployed
Number of subjects: 522
Study 11318256 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents living with two parents
Number of subjects: 522
Study 9133695 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine treatment with a standard activity of 15 mCi (555 MBq) of 131I
Number of subjects: 205
Study 9133695 — intervention group
Group type: EXPERIMENTAL
Intervention: Target dose of 100 Gy
Number of subjects: 205
Study 9133695 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard activity (15 mCi) with additional calculation of actual target dose
Number of subjects: 205
Study 9133695 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid volume reduction
Number of subjects: 205
Study 7898964 — intervention group
Group type: COMPARATOR
Intervention: Exosurf Neonatal (artificial surfactant)
Number of subjects: 24
Study 7898964 — intervention group
Group type: EXPERIMENTAL
Intervention: Curosurf (natural porcine surfactant)
Number of subjects: 24
Study 3307900 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine (2 mg/kg)
Number of subjects: 35
Study 3307900 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 35
Study 31868051 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Oscillation Technique (FOT)
Number of subjects: 154
Study 31868051 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Plethysmography
Number of subjects: 154
Study 31868051 — intervention group
Group type: COMPARATOR
Intervention: Control Group (Healthy Controls)
Number of subjects: 154
Study 30113646 — intervention group
Group type: COMPARATOR
Intervention: Amino acid concentrations in South‐Asian Surinamese women
Number of subjects: 700
Study 30113646 — intervention group
Group type: COMPARATOR
Intervention: Acylcarnitine and amino acid levels in South‐Asian Surinamese men
Number of subjects: 700
Study 30113646 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolite levels
Number of subjects: 700
Study 30113646 — intervention group
Group type: EXPERIMENTAL
Intervention: Results after adjustment for body mass index and intake of fat and total energy
Number of subjects: 700
Study 26993629 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive cognitive therapy with gradual, guided discontinuation of SSRIs under medical management (STOP)
Number of subjects: 200
Study 26993629 — intervention group
Group type: COMPARATOR
Intervention: Continuation of SSRIs (GO)
Number of subjects: 200
Study 26993629 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive cognitive therapy with gradual, guided discontinuation of SSRIs (STOP)
Number of subjects: 200
Study 25825421 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (40 units into each pectoralis major muscle through 4 serial injections)
Number of subjects: 30
Study 25825421 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 30
Study 25825421 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl, 4 serial injections)
Number of subjects: 30
Study 25825421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 23380314 — intervention group
Group type: EXPERIMENTAL
Intervention: l-5-hydroxytryptophan (l-5-HTP)
Number of subjects: 60
Study 23380314 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 60
Study 19952819 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-min lower-body cold-water immersion
Number of subjects: 8
Study 19952819 — intervention group
Group type: COMPARATOR
Intervention: No cooling intervention (control)
Number of subjects: 8
Study 17869052 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal violence exposure
Number of subjects: 238
Study 17869052 — intervention group
Group type: COMPARATOR
Intervention: No violence exposure
Number of subjects: 238
Study 16169344 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA) followed by beta-radiation therapy
Number of subjects: 113
Study 16169344 — intervention group
Group type: COMPARATOR
Intervention: Cutting balloon angioplasty (CBA) followed by beta-radiation therapy
Number of subjects: 113
Study 12848680 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagent (perflexane lipid microspheres) administered as an IV bolus at 0.125 mg/kg body weight
Number of subjects: 409
Study 12848680 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagent
Number of subjects: 409
Study 12848680 — intervention group
Group type: COMPARATOR
Intervention: Noncontrast echocardiography
Number of subjects: 409
Study 10534058 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine, methotrexate, and prednisone (CSA/MTX/PSE)
Number of subjects: 149
Study 10534058 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine and prednisone (CSA/PSE)
Number of subjects: 149
Study 10534058 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 149
Study 15321322 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with 2.0 ml hyperbaric 0.5% bupivacaine
Number of subjects: 40
Study 15321322 — intervention group
Group type: COMPARATOR
Intervention: Epidural anaesthesia with a local anaesthetic mixture (0.5% bupivacaine plain 10 ml, 2% lignocaine plain 10 ml, 0.1 ml of adrenaline 1 in 1000, and 2 ml of 8.4% sodium bicarbonate)
Number of subjects: 40
Study 15321322 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 40
Study 15321322 — intervention group
Group type: COMPARATOR
Intervention: Epidural anaesthesia
Number of subjects: 40
Study 1817663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantamega‐2000 (1 tablet daily at breakfast for 4 weeks)
Number of subjects: 20
Study 1817663 — intervention group
Group type: COMPARATOR
Intervention: Polivitaminizant S (2 tablets daily at breakfast for 4 weeks)
Number of subjects: 20
Study 1817663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantamega‐2000
Number of subjects: 20
Study 6812449 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide (F)
Number of subjects: 125
Study 30663977 — intervention group
Group type: EXPERIMENTAL
Intervention: IBI305 (3 mg/kg)
Number of subjects: 100
Study 30663977 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 100